Most Accessed Articles: Cardiovascular Diabetologyhttps://cardiab.biomedcentral.comMost Accessed Articles: Cardiovascular DiabetologyComparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-11-92No previous studies have compared the DPP-4 inhibitors vildagliptin and sitagliptin in terms of blood glucose levels using continuous glucose monitoring (CGM) and cardiovascular parameters.Original investigationMon, 06 Aug 2012 00:00:00 GMThttps://cardiab.biomedcentral.com/articles/10.1186/1475-2840-11-92Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando and Kazunori Utsunomiya2012-08-06T00:00:00ZHow hyperglycemia promotes atherosclerosis: molecular mechanismshttps://cardiab.biomedcentral.com/articles/10.1186/1475-2840-1-1Both type I and type II diabetes are powerful and independent risk factors for coronary artery disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually 80% of all deaths a...ReviewMon, 08 Apr 2002 00:00:00 GMThttps://cardiab.biomedcentral.com/articles/10.1186/1475-2840-1-1Doron Aronson and Elliot J Rayfield2002-04-08T00:00:00ZBeneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot studyhttps://cardiab.biomedcentral.com/articles/10.1186/1475-2840-8-35Our aim was to compare the effects of a Paleolithic ('Old Stone Age') diet and a diabetes diet as generally recommended on risk factors for cardiovascular disease in patients with type 2 diabetes not treated w...Original investigationThu, 16 Jul 2009 00:00:00 GMThttps://cardiab.biomedcentral.com/articles/10.1186/1475-2840-8-35Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, Anita Hansson, Margareta Söderström and Staffan Lindeberg2009-07-16T00:00:00ZPersistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasminhttps://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01359-7Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute clinical pathologies, including various coagulopathie...Original investigationMon, 23 Aug 2021 00:00:00 GMThttps://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01359-7Etheresia Pretorius, Mare Vlok, Chantelle Venter, Johannes A. Bezuidenhout, Gert Jacobus Laubscher, Janami Steenkamp and Douglas B. Kell2021-08-23T00:00:00ZAssociation between insulin resistance and the development of cardiovascular diseasehttps://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0762-4For many years, cardiovascular disease (CVD) has been the leading cause of death around the world. Often associated with CVD are comorbidities such as obesity, abnormal lipid profiles and insulin resistance. I...ReviewFri, 31 Aug 2018 00:00:00 GMThttps://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0762-4Valeska Ormazabal, Soumyalekshmi Nair, Omar Elfeky, Claudio Aguayo, Carlos Salomon and Felipe A. Zuñiga2018-08-31T00:00:00Z